Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Oncology

• Publication date

  2003-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2003.05.096PMID 12586815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary breast cancer and family cancer syndromes

  2004cited by this paper
• Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

  2002cited by this paper
• The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

  2002cited by this paper
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

  2002cited by this paper
• Cancer Statistics, 2002

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Identification and referral of families at high risk for cancer susceptibility.

  2002cited by this paper
• Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

  2002cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Oncology nurse training in cancer genetics

  2001cited by this paper
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

  2001cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

  2001cited by this paper
• High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood

  2001cited by this paper
• Qualitative Cancer Genetic Counseling Research, Part I: Ethnography in a Cancer Clinic

  2001cited by this paper
• Gene-expression profiles in hereditary breast cancer.

  2001cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• Genomics and future biological weapons: the need for preventive action by the biomedical community

  2001cited by this paper
• Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer

  2001cited by this paper
• Prophylactic mastectomy: obstacles and benefits.

  2001cited by this paper
• Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations

  2001cited by this paper
• A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

  2001cited by this paper
• Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

  2001cited by this paper
• Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

  2001cited by this paper
• Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

  2001cited by this paper
• Qualitative Cancer Genetic Counseling Research, Part II: Findings from a Exploratory Ethnographic Study in a Cancer Clinic

  2001cited by this paper
• Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

  2001cited by this paper
• Family information service and hereditary cancer

  2001cited by this paper
• Predominance of brain tumors in an extended Li‐Fraumeni (SBLA) kindred, including a case of Sturge‐Weber syndrome

  2000cited by this paper
• Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

  2000cited by this paper
• Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.

  2000cited by this paper
• Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.

  2000cited by this paper
• Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray.

  2000cited by this paper
• Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

  2000cited by this paper
• Linking gene expression patterns to therapeutic groups in breast cancer.

  2000cited by this paper
• Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

  2000cited by this paper
• Screening for ovarian cancer: what we know, what we need to know.

  2000cited by this paper
• Uncovering functionally relevant signaling pathways using microarray-based expression profiling.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

  2000cited by this paper
• Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

  1999cited by this paper
• Genetic susceptibility for specific cancers

  1999cited by this paper
• BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations.

  1999cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• Molecular biology in radiation oncology. Radiation oncology perspective of BRCA1 and BRCA2.

  1999cited by this paper
• Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.

  1999cited by this paper
• Breast Cancer Genes and DNA Repair

  1999cited by this paper
• A family with three germline mutations in BRCAl and BRCA2

  1998cited by this paper
• Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells.

  1998cited by this paper
• Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

  1998cited by this paper
• A step toward genotype-based therapeutic regimens for breast cancer in patients with BRCA2 mutations?

  1998cited by this paper
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

  1997cited by this paper
• A descriptive study of BRCA1 testing and reactions to disclosure of test results

  1997cited by this paper
• Brca2 hereditary breast cancer pathophenotype

  1997cited by this paper
• Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

  1997cited by this paper
• BRCA1 and BRCA2 hereditary breast carcinoma phenotypes

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Breast carcinoma litigation

  1997cited by this paper
• Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancer

  1996cited by this paper
• Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

  1996cited by this paper
• Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors.

  1995cited by this paper
• National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up.

  1994cited by this paper
• Screening for ovarian carcinoma: hopeful and wishful thinking.

  1994cited by this paper
• The potential use of tumor registry data in the recognition and prevention of hereditary and familial cancer.

  1991cited by this paper
• Cancer and the family history trail.

  1991cited by this paper
• Incidence of cancer in 161 families affected by ataxia-telangiectasia.

  1991cited by this paper
• Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma

  1978cited by this paper
• Tumor variation in families with breast cancer.

  1972cited by this paper
• Carcinoma of the breast and ovary in three families.

  1971cited by this paper

• Comprehensive profiling of somatic alterations and HRD characteristics in Chinese germline BRCA-mutated breast cancer patients.

  2026cites this paper
• TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing

  2021cites this paper
• Tumour predisposition and cancer syndromes as models to study gene–environment interactions

  2020cites this paper
• Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family

  2020cites this paper
• Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer

  2017cites this paper
• The Surgical and Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers

  2016cites this paper
• Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use

  2016cites this paper
• Cancer Risk Management Decision Making for BRCA+ Women

  2015cites this paper
• Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

  2015cites this paper
• Screening Mammography Among Women With A Family History Of Breast Cancer

  2014cites this paper
• Management of Hereditary Ovarian–Breast Cancer

  2014cites this paper
• The Different Impact of BRCA Mutations on the Survival of Epithelial Ovarian Cancer Patients: A Retrospective Single-Center Experience

  2013cites this paper
• Hereditary Breast Cancer: Practical Pursuit for Clinical Translation

  2012cites this paper
• Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort

  2011cites this paper
• Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.

  2010cites this paper
• Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal

  2010cites this paper
• Strategies of hormonal prevention.

  2009cites this paper
• Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting

  2009influential citation
• Korean Hereditary Breast Cancer

  2009cites this paper
• Family Information Service Participation Increases the Rates of Mutation Testing Among Members of Families with BRCA1/2 Mutations

  2009cites this paper
• Hereditary Breast Cancer: Part I. Diagnosing Hereditary Breast Cancer Syndromes

  2008cites this paper
• Hereditary Factors in Endometrial Cancer

  2007cites this paper
• Inherited Breast Cancer

  2007cites this paper
• Risk and risk assessment for breast cancer: molecular and clinical aspects.

  2007cites this paper
• Evaluation of mathematical models for breast cancer risk assessment in routine clinical use

  2007cites this paper
• Operative ÜBerlegungen beim Familiôren Mammakarzinom

  2007cites this paper
• Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

  2006cites this paper
• Moving genetics into clinical cancer care: examples from BRCA gene testing and telemedicine.

  2006cites this paper
• The bridge from genomic discoveries to disease prevention. 2006 Oncology Nursing Society Clinical Lectureship.

  2006cites this paper
• Genomic tests for ovarian cancer detection and management.

  2006cites this paper
• Utrata heterozygotyczności loci sprzężonych z genami BRCA1 i BRCA2 w rakach jajnika

  2006cites this paper
• Patients with a family history of cancer: identification and management.

  2005cites this paper
• Factors Influencing Uptake of Genetic Testing For Colorectal Cancer Risk in an Australian Jewish Population

  2005cites this paper
• What the physician needs to know about Lynch syndrome: an update.

  2005cites this paper
• Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey

  2005cites this paper
• BRCA1 Genetic Mutation and Its Link to Ovarian Cancer: Implications for Advanced Practice Nurses

  2005cites this paper
• Familial breast cancer: Genetics and counseling Familial breast cancer: Genetics and counseling Familial breast cancer: Genetics and counseling Familial breast cancer: Genetics and counseling Familial breast cancer: Genetics and counseling

  2005cites this paper
• Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility

  2005cites this paper
• Challenging pedigrees seen in a hereditary cancer consultation center.

  2004cites this paper
• Characterization of Two Novel BRCA1 Germ-Line Mutations Involving Splice Donor Sites

  2004cites this paper
• Hereditary breast cancer in Jews

  2004cites this paper
• Genetic counseling for familial conditions during pregnancy: an analysis of patient characteristics

  2004cites this paper
• Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.

  2004cites this paper
• Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama.

  2004cites this paper
• A clinical, histopathological, and genetic study of Avellino corneal dystrophy in British families

  2003cites this paper
• Genetic counselors: translating genomic science into clinical practice.

  2003cites this paper
• Hereditary breast cancer: shared communication and care.

  2003cites this paper